Does thiamine supplementation affect heart failure? A systematic review and meta-analysis of randomized control trials

被引:18
|
作者
Syed, Abdul Rehman Shah [1 ]
Syed, Abdul Ahad [2 ]
Akram, Abdullah [2 ]
Azam, Muhammad Shaheryar [2 ]
Muzammil, Muhammad Ali [2 ]
Deepak [3 ]
Ansari, Ayesha Irshad [2 ]
Eqbal, Farea [2 ]
Farooq, Muhammad Haris [2 ]
Khatri, Mahima [4 ]
Kumar, Satesh [5 ]
Kumar, Nomesh [6 ]
机构
[1] Dow Univ Hlth Sci Med, H2 G50-4-2-2 Umar banglows Abdul Rehman St garden, Karachi, Pakistan
[2] Dow Univ Hlth Sci, Karachi, Pakistan
[3] Shaheed Mohtarma Benazir Bhuttoto Med Coll Lyari, Karachi, Pakistan
[4] Dow Univ Hlth Sci, Karachi, Pakistan
[5] Shaheed Mohtarma Benazir Bhutto Med Coll, Karachi, Pakistan
[6] Wayne state Univ Sinai Grace, Detroit Med Ctr, Multan, Pakistan
来源
HEART & LUNG | 2023年 / 61卷
关键词
Heart failure; Thiamine; Older patients; Meta-analysis; LVEF; LVEDV; NT-PRO BNP; LEFT-VENTRICULAR FUNCTION; QUALITY-OF-LIFE; ELDERLY-PATIENTS; DOUBLE-BLIND; MANAGEMENT; DEFICIENCY;
D O I
10.1016/j.hrtlng.2023.04.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Heart failure is a pathophysiological condition where decreased cardiac output is observed sub-sequent to any structural deformity or cessation of normal function. Thiamine deficiency is one of the risk factors responsible for causing HF; other risk factors include hypertension, smoking, and obesity.Objective: We conducted a systemic review and meta-analysis of RCTs to scrutinize whether the heart failure patients would benefit from thiamine supplementation or not when compared to placebo. Methods: We selected only those double-arm randomized controlled trials (RCTs) which included partici-pants presenting with symptomatic heart failure. We excluded all the articles published in languages other than English Language. Furthermore, all the studies other than RCTs were also omitted. Articles yielded from the electronic search were exported to EndNote Reference Library software to remove any duplicates. Analy-ses were done using the Review manager 5.4 tool. Mean values and standard deviations were retrieved for the continuous outcomes given as raw data.Results: The 6 RCTs selected for the statistical analysis consisted of 298 participants (158 in the intervention group, 140 in the placebo group). The outcomes resulted to be non-significant with LVEF p-value= 0.08, NT-pro BNP p-value= 0.94, LVEDV p-value= 0.53, 6MWT p-value=0.59, mortality p-value= 0.61, hospitalization p-value= 0.53 and dyspnea p-value= 0.77. Heart rate is the only significant outcome with a p-value=0.04.Conclusion: To conclude, except for heart rate, thiamine supplementation had no effect on the outcomes of heart failure patients.(c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:37 / 45
页数:9
相关论文
共 50 条
  • [41] CARDIORENAL OUTCOMES OF EMPAGLIFLOZIN IN ACUTE HEART FAILURE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Borges, Rafael
    Navalha, Denilsa
    Oliveira, Gustavo
    Alves, Vinicius
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 563 - 563
  • [42] Vasopressin receptor antagonists for the treatment of heart failure: a systematic review and meta-analysis of randomized controlled trials
    Nistor, Ionut
    Bararu, Iris
    Apavaloaie, Maria-Cristina
    Voroneanu, Luminita
    Donciu, Mihaela-Dora
    Kanbay, Mehmet
    Nagler, Evi V.
    Covic, Adrian
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2015, 47 (02) : 335 - 344
  • [43] Vasopressin receptor antagonists for the treatment of heart failure: a systematic review and meta-analysis of randomized controlled trials
    Nistor, I.
    Bararu, I.
    Apavaloaie, M. C.
    Voroneanu, L.
    Donciu, M. D.
    Nagler, E. V.
    Covic, A.
    EUROPEAN HEART JOURNAL, 2014, 35 : 181 - 181
  • [44] Vasopressin receptor antagonists for the treatment of heart failure: a systematic review and meta-analysis of randomized controlled trials
    Ionut Nistor
    Iris Bararu
    Maria-Cristina Apavaloaie
    Luminita Voroneanu
    Mihaela-Dora Donciu
    Mehmet Kanbay
    Evi V. Nagler
    Adrian Covic
    International Urology and Nephrology, 2015, 47 : 335 - 344
  • [45] Torsemide versus Furosemide in the Treatment of Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Teixeira, Larissa
    Felix, Nicole
    Navalha, Denilsa D. P.
    Ferreira, Rafael
    Clemente, Mariana R. C.
    Madeira, Thiago
    Nogueira, Alleh
    Tramujas, Lucas
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2024, 121 (06)
  • [46] INTRAVENOUS IRON INFUSION IN PATIENTS WITH HEART FAILURE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS
    El Iskandarani, Mahmoud
    Shatla, Islam
    Jamil, Yasser
    Elajami, Tarec
    Paul, Timir K.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 744 - 744
  • [47] Does anthocyanins consumption affect weight and body composition? A systematic review and meta-analysis of randomized controlled trials
    Yarhosseini, Faezeh
    Darand, Mina
    Sangsefidi, Zohreh Sadat
    Mozaffari-Khosravi, Hassan
    Hosseinzadeh, Mahdieh
    OBESITY SCIENCE & PRACTICE, 2023, 9 (01): : 42 - 58
  • [48] Oral iron supplementation in patients with heart failure: a systematic review and meta-analysis
    Song, Zhiping
    Tang, Mingyang
    Tang, Gang
    Fu, Guoqi
    Ou, Dengke
    Yao, Fengyou
    Hou, Xingzhi
    Zhang, Denghong
    ESC HEART FAILURE, 2022, 9 (05): : 2779 - 2786
  • [49] Can flaxseed supplementation affect circulating adipokines in adults? An updated systematic review and meta-analysis of randomized controlled trials
    Abbasi, Shaghayegh
    Karimi, Kiana
    Hossein Moridpour, Amir
    Musazadeh, Vali
    Faghfouri, Amir Hossein
    Jozi, Hannane
    FRONTIERS IN NUTRITION, 2023, 10
  • [50] Chromium supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials
    Onakpoya, I.
    Posadzki, P.
    Ernst, E.
    OBESITY REVIEWS, 2013, 14 (06) : 496 - 507